(Q44479135)

3 December 2017

3-Methylethergalangin isolated from Alpinia officinarum inhibits pancreatic lipase (English)

1 reference

3 December 2017

1 reference

1 reference

Ji-Eun Shin

1

1 reference

PubMed ID

12808299

3 December 2017

Myung Joo Han

series ordinal

2

1 reference

PubMed ID

12808299

3 December 2017

Dong-Hyun Kim

series ordinal

3

1 reference

3 December 2017

2003

1 reference

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/bpb/26/6/26_6_854/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/bpb.26.854?email=unpaywall_01@example.com

published in

Biological and Pharmaceutical Bulletin

1 reference

3 December 2017

26

1 reference

3 December 2017

6

1 reference

3 December 2017

854-857

1 reference

https://api.unpaywall.org/v2/10.1248/bpb.26.854?email=unpaywall_01@example.com

3 December 2017

1 reference

19 March 2024

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

780 SE: a new type of hypolipemic agent. Comparative assays in rats

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.26.854

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.26.854

Lipid Digestion and Absorption

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.26.854

[Pharmacological investigation of bezafibrate, a hypolipidemic agent (1). Effects of bezafibrate on normal and experimental hyperlipidemia in rats]

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.26.854

Orlistat: its current status as an anti-obesity drug

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.26.854

Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemia.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/BPB.26.854

Identifiers

DOI

10.1248/BPB.26.854

1 reference

3 December 2017

1 reference

PubMed ID

12808299